Immune Thrombocytopenic Purpura (ITP)
August 29, 2024
Immune thrombocytopenic purpura (ITP) is a rare but serious complication that happens in an estimated 1-5% of those living with CLL and SLL.
Immune thrombocytopenic purpura (ITP) is a rare but serious complication that happens in an estimated 1-5% of those living with CLL and SLL.
Immune thrombocytopenic purpura (ITP) is a rare but serious complication that happens in an estimated 1-5% of those living with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).
Autoimmune hemolytic anemia (AIHA) is the most common autoimmune condition associated with CLL and SLL.
Autoimmune disorders occur when the body’s immune system mistakenly attacks and damages
healthy cells.
Autoimmune hemolytic anemia (AIHA) is the most common autoimmune condition associated with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).
Since CLL is a cancer of the immune system, some of the most serious complications associated with CLL are related to immune dysfunction.
March 2026 CLL Bloodline: The CLL Society Bloodline will teach the BASICS needed to understand CLL.
Access important medications in the CLL Society Clinician Medicine Cabinet. Download key resources and order a Welcome Kit.
Discover CLL Society Clinician Resource Library CME offerings to improve care approaches for CLL and SLL patients.